Nxstage Medical Inc (NXTM)
30.00 +0.01 (+0.03%) 02/21/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Thu, Feb 21st, 2019
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
Cash Flows From Operating Activities | |||||
Net Income | -15,325 | -7,317 | -16,260 | -24,313 | -18,561 |
Depreciation Amortization | 33,754 | 32,637 | 30,715 | 27,697 | 24,848 |
Accounts receivable | 1,056 | -7,388 | -1,130 | -4,188 | -1,095 |
Accounts payable and accrued liabilities | -22 | 3,532 | -2,775 | -212 | -2,233 |
Other Working Capital | -27,295 | -33,295 | -17,813 | -38,415 | -27,694 |
Other Operating Activity | 12,634 | 16,418 | 17,805 | 19,158 | 14,594 |
Operating Cash Flow | $4,802 | $4,587 | $10,542 | $-20,273 | $-10,141 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 0 | 0 | 676 | N/A | N/A |
PPE Investments | -9,194 | -8,848 | -11,537 | -20,097 | -16,246 |
Net Acquisitions | -100 | -513 | N/A | N/A | -2,234 |
Purchase Of Investment | -2,500 | 0 | 0 | N/A | N/A |
Investing Cash Flow | $-11,794 | $-9,361 | $-10,861 | $-20,097 | $-18,480 |
Cash Flows From Financing Activities | |||||
Debt Issued | 452 | 0 | 1,275 | N/A | 1,136 |
Debt Repayment | -1,470 | -1,974 | -1,534 | -1,546 | -1,390 |
Common Stock Issued | 12,003 | 5,994 | 6,663 | 11,133 | 5,484 |
Other Financing Activity | 0 | 1,255 | 929 | -126 | 525 |
Financing Cash Flow | $10,985 | $5,275 | $7,333 | $9,461 | $5,755 |
Exchange Rate Effect | 1,303 | 66 | -833 | -341 | 561 |
Beginning Cash Position | 59,632 | 59,065 | 52,884 | 84,134 | 106,439 |
End Cash Position | 64,928 | 59,632 | 59,065 | 52,884 | 84,134 |
Net Cash Flow | $5,296 | $567 | $6,181 | $-31,250 | $-22,305 |
Free Cash Flow | |||||
Operating Cash Flow | 4,802 | 4,587 | 10,542 | -20,273 | -10,141 |
Capital Expenditure | -9,194 | -8,848 | -11,537 | -20,097 | -16,246 |
Free Cash Flow | -4,392 | -4,261 | -995 | -40,370 | -26,387 |